ON THE ORIGIN OF LUNG CANCER DEVELOPMENT.

Q3 Medicine

Experimental oncology Pub Date : 2022-05-01 DOI:10.32471/exp-oncology.2312-8852.vol-44-no-1.17227

L. Bolgova, T. Tuganova, O. I. Alekseenko, A. Ponomarenko

引用次数: 1

Abstract

In the review on the issues of histogenesis of lung cancer (LC), the significant results of experimental, pathological, immunohistochemical and molecular-biological studies are presented. However, until now, no data has been obtained that would allow scientists to come to an unambiguous decision about the origin and development of this disease. The question remains not yet fully understood, since researchers discuss the origin of LC development in a hypothetical form. This situation poses the task of further in-depth scientific research, which would make it possible to clarify the unambiguous origin of LC development, and, therefore, would allow solving the problem of its early diagnosis and create grounds for screening programs, which is of high scientific and clinical significance.

查看原文本刊更多论文

肺癌发展的起源。

本文综述了肺癌组织发生的实验、病理、免疫组织化学和分子生物学等方面的重要研究成果。然而，直到现在，还没有数据可以让科学家对这种疾病的起源和发展做出明确的决定。这个问题还没有完全被理解，因为研究人员以一种假设的形式讨论了LC发展的起源。这种情况提出了进一步深入科学研究的任务，这将有可能澄清LC发展的明确起源，从而解决其早期诊断问题，并为筛查方案提供依据，具有很高的科学和临床意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Experimental oncology Medicine-Oncology

CiteScore

1.40

自引率

0.00%

发文量

期刊介绍： The Experimental Oncology is an English-language journal that publishes review articles, original contributions, short communications, case reports and technical advances presenting new data in the field of experimental and fundamental oncology. Manuscripts should be written in English, contain original work, which has not been published or submitted for publication elsewhere. It also implies the transfer of the Copyright from the author to “Experimental Oncology”. No part of journal publications may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the prior permission of the publisher.